Caries Clinical Trial
Official title:
Randomized Controlled Clinical Trial (RCT) of the New Tooth-colored Restorative Material 'Cention Forte' (Ivoclar Vivadent) vs. 'Equia Forte HT' (GC) in Class-I/II Cavities
Verified date | March 2024 |
Source | Ivoclar Vivadent AG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized-controlled clinical trial to investigate the success rate of two new tooth-colored restorative materials in class I and II cavities over 5 years according to FDI criteria scores (1, 2 and 3).
Status | Active, not recruiting |
Enrollment | 58 |
Est. completion date | April 1, 2028 |
Est. primary completion date | April 1, 2028 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Subject's age between 18 and 65 years old - Class I and Class II (with a cavity margin 1-1.5 mm from the cusp tip) (caries treatment, removal of existing defective amalgam/composite restorations), on premolars/molars - Vital teeth - 2 restorations per patient: both cavities should have comparable size and dimensions - Presence of neighbour tooth and antagonist (molars with no neighbour tooth at the distal side can also be included) - Low to moderate caries rate/normal periodontal status with good home care Exclusion Criteria: - Hospitalized and medically compromised patients (medical history may not compromise the outcome of the results) - Pulp exposure or signs of pulpal infection - No signs of pulpitis or hypersensitivity (Visual analog scale < 3 on biting and temperature sensitivity) - History of allergy to glass ionomer, acrylate/methacrylate monomers - Pregnancy - Chronic disease with oral manifestations or primary oral pathology - Bad oral hygiene - High caries rate or periodontal problems - Absence of antagonists - Absence of adjacent teeth (except last molar in the row with no neighbour tooth at the distal side) |
Country | Name | City | State |
---|---|---|---|
Belgium | KU Leuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
Ivoclar Vivadent AG | KU Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Success Rate | assessed following FDI criteria on a scale from 1 "very good" to 5 "unacceptable": e.g. post-operative hypersensitivity, surface lustre, staining, fracture of material, retention, occlusal contour and wear, and colour match of restorations (Success: Scores equal to/above 3) | 5 years | |
Secondary | Success Rate | assessed following FDI criteria on a scale from 1 "very good" to 5 "unacceptable": e.g. post-operative hypersensitivity, surface lustre, staining, fracture of material, retention, occlusal contour and wear, and colour match of restorations (Success: Scores equal to/above 3) | 6 months to 3 years | |
Secondary | Survival Rate | assessed following FDI criteria on a scale from 1 "very good" to 5 "unacceptable": e.g. post-operative hypersensitivity, surface lustre, staining, fracture of material, retention, occlusal contour and wear, and colour match of restorations (Survival: Score equal to/above 4) | 6 months to 5 years | |
Secondary | Quality criteria (Clinical performance) | assessed following FDI criteria on a scale from 1 "very good" to 5 "unacceptable": e.g. post-operative hypersensitivity, surface lustre, staining, fracture of material, retention, occlusal contour and wear, and colour match of restorations | 6 months to 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05311657 -
Oral Health and Severe COPD
|
||
Not yet recruiting |
NCT06438926 -
Prevalence of Dental Caries in Patients With Dental Crowding
|
||
Completed |
NCT01529606 -
Cold Plasma for Dental Restoration and Caries Prevention
|
N/A | |
Completed |
NCT06072742 -
Effect of Lifestyle on Caries and Apical Periodontitis
|
||
Completed |
NCT04679558 -
Antibacterial Effect of Chlorhexidine Added to the Preventive Protocol in Adolescent Special Needs
|
Early Phase 1 | |
Active, not recruiting |
NCT04933123 -
Clinical Evaluation of a Dental Glass Ceramic in the Indirect Restorative Therapy
|
N/A | |
Withdrawn |
NCT02202304 -
The Effects of Chlorhexidine/Thymol Varnish on Partial Denture Patient
|
Phase 4 | |
Not yet recruiting |
NCT04889196 -
The Efficiency and Gingival Health Status of Hall Versus SDF Techniques in the Management of Carious Primary Molars
|
Phase 3 | |
Active, not recruiting |
NCT04708223 -
Prospective, Split-mouth, Comparative Study to Compare Clinical Outcomes of Two Different Posterior Composite
|
N/A | |
Completed |
NCT06140745 -
Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial
|
N/A | |
Recruiting |
NCT05144711 -
Management of Deep Carious Lesions in Adults
|
N/A | |
Not yet recruiting |
NCT03656432 -
Effect of CPP-ACP With/Without Fl on White Spot Lesion,Salivary pH and fl Release in High Caries Risk Patients
|
Phase 3 | |
Not yet recruiting |
NCT02933463 -
Clinical Effectiveness of Embrace Wetbond and Clinpro as Pits and Fissure Sealants in Young Permanent Molars
|
N/A | |
Completed |
NCT02998814 -
Clinical Follow Up of a Fissure Sealant Placed With Different Adhesive Protocols: 2-Year Randomized Split Mouth Study
|
N/A | |
Completed |
NCT02027597 -
Improving Oral Health With Serious Games
|
N/A | |
Not yet recruiting |
NCT05064566 -
Evaluation of Caries Detection Methods
|
||
Completed |
NCT06010732 -
In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice
|
Phase 3 | |
Recruiting |
NCT05211843 -
Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries
|
N/A | |
Not yet recruiting |
NCT05070416 -
Lithium Disilicate Crowns Study
|
N/A | |
Completed |
NCT02418520 -
The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
|
N/A |